Is An End To The Combination Therapy Pricing Problem In Sight In The UK?

Indication-based pricing and tackling complications caused by competition law could help the UK catch up with other countries when it comes to market access for combination therapies.

 Ladder made of coins with colorful pills on top suggesting the growing prices of medicine or drugs
Pricing of combination treatments poses a challenge

Indication-based pricing and a new approach to negotiating between companies to address issues arising from UK competition law will be key to ensuring that combination therapies reach patients, heard delegates at a 4 May online event, Confronting The Challenge Of Combination Treatments.

Though speakers at the event agreed that some drugs might end up with a lower price, they appealed to industry...

More from Europe

More from Geography